Meshima Mushroom: Immune Research Profile and Evidence Status

Meshima (Phellinus linteus) is a hard, hoof-shaped mushroom used in traditional Asian medicine for centuries. Laboratory and animal studies suggest it contains compounds, including polysaccharides and beta-glucans, that interact with immune cells. Human clinical evidence, however, is extremely limited, and no major health authority has approved meshima to prevent, treat, or cure any disease.

Important Safety Notes Before You Read Further

People with autoimmune conditions should use caution. A published case report described a flare of pemphigus, an autoimmune blistering skin condition, linked to meshima use.
Because meshima may stimulate immune activity, anyone taking immunosuppressant medicine, preparing for organ transplant, or managing an autoimmune disease should talk with their treating clinician before use.
Formal drug-interaction studies in humans are lacking. This is a gap in the evidence, not a safety guarantee.
Meshima supplements are not reviewed by the FDA for safety or effectiveness before they reach the market.

Traditional Use History

Meshima grows mainly on mulberry trees and other hardwoods in East Asia. It is also known as black hoof mushroom, mesima, meshimakobu in Japan, and sanghuang in China. Practitioners in Japan, Korea, and China have used it in traditional medicine for generations, historically associated with digestive complaints, inflammation, and general vitality. Traditional use reflects long-standing cultural practice, not confirmed medical benefit. It does not substitute for evidence from controlled human research.

What Laboratory and Animal Research Show

Most of what scientists know about meshima comes from cell (in-vitro) and animal studies, not from people. This early-stage research is useful for generating hypotheses, but it often does not predict what happens in the human body.

Immune cell activity: In laboratory research, an extract combination containing meshima alongside bamboo leaf and chaga mushroom activated macrophages, a type of immune cell involved in identifying and clearing harmful material. This tested meshima as part of a three-ingredient mixture, not as a stand-alone extract.
Tumor growth in animal models: That same combination extract reduced tumor growth in several mouse cancer models, including implanted tumors and chemically induced cancers. Again, this reflects a combination product rather than meshima alone.
Anti-inflammatory and antioxidant signals: Separate preclinical studies point to anti-inflammatory and antioxidant activity from meshima compounds, but these findings come from cell cultures and animals, not from clinical trials in people.

None of these findings confirm that meshima prevents, treats, or cures any disease in humans. Preclinical results frequently fail to replicate in human trials.

Why Human Clinical Evidence Is So Limited

Human research on meshima is sparse compared to better-studied mushrooms like turkey tail or reishi. According to Memorial Sloan Kettering Cancer Center’s integrative medicine information service, one study has looked at meshima as an add-on therapy in pancreatic cancer patients, and there are a few case reports describing regression of liver or prostate cancer in individuals already receiving other treatment. These are not the same as randomized, controlled trials, and researchers describing this work say well-designed studies are still needed to confirm any effect.

Meshima also does not appear to have a dedicated fact sheet in the National Center for Complementary and Integrative Health’s Herbs at a Glance series or the NIH Office of Dietary Supplements fact sheet library, the kind of review given to more thoroughly studied botanicals and supplements. That absence is informative on its own: it reflects how little large-scale, government-reviewed human research currently exists for this specific mushroom.

Evidence at a Glance

Traditional use: Centuries of use in Chinese, Korean, and Japanese medicine. This shows cultural history, not proof of safety or effectiveness by modern standards.
In-vitro (cell) studies: Immune cell activation and antiproliferative activity against cancer cells in laboratory dishes. This does not show how the compound behaves inside a living human body.
Animal studies: Reduced tumor growth in specific mouse cancer models. This does not show equivalent results in human patients.
Human case reports: Isolated reports of possible benefit or harm, including the pemphigus flare noted above. Case reports cannot prove cause and effect or rule out coincidence.
Controlled human trials: Currently very limited for most claimed uses. This is the evidence tier still needed before firm conclusions can be drawn.

Extra-Caution Groups

People with autoimmune disease: Immune-stimulating compounds could theoretically worsen autoimmune activity, as suggested by the pemphigus case report above.
People on immunosuppressant therapy: Meshima’s proposed immune-activating effects could work against the purpose of these medicines.
People with upcoming surgery: Effects on bleeding or immune response around surgery have not been well studied for meshima specifically. Mention any supplement use to your surgical team.
Pregnant or breastfeeding people: There is not enough safety data to support use in pregnancy or lactation.
People taking prescription medicine for cancer or chronic disease: Ask a pharmacist or physician before adding any mushroom supplement, since interaction data is limited.

How to Evaluate a Meshima Supplement Claim

Check whether the product identifies the exact species, Phellinus linteus, rather than a vague “immune mushroom blend.”
Look for whether the claim cites a human clinical trial or only animal and lab research.
Be skeptical of any product claiming to treat, cure, or prevent cancer or any other disease. This is not supported by current evidence and is a regulatory red flag.
Notice whether fruiting body or mycelium is used, since these can differ in composition.
See if the company discloses third-party testing for identity and contaminants.
Ask a pharmacist or physician to review any product against your current medications before starting it.

Frequently Asked Questions

Is meshima the same as turkey tail or reishi mushroom?

No. Meshima is a distinct species, Phellinus linteus. It is sometimes grouped with turkey tail and reishi in immune-support marketing, but each mushroom has its own chemical makeup and its own, generally limited, evidence base.

Does meshima actually boost the immune system in people?

Laboratory and animal studies suggest immune-activating effects, but controlled human trials confirming this in people are lacking. Marketing claims of proven immune-boosting effects in humans go beyond what current evidence supports.

Can I take meshima with my prescription medication?

There is not enough research to say this is safe for every medication. Because meshima may affect immune activity, talk with your prescribing clinician or pharmacist before combining it with any prescription drug, especially immunosuppressants.

Why don’t major health agencies have more information on meshima?

Meshima has received far less large-scale, government-reviewed research than better-known mushrooms like reishi or turkey tail. The absence of a dedicated NCCIH or NIH Office of Dietary Supplements fact sheet reflects this evidence gap. It is not a certification of safety.

Educational Disclaimer

This article is for general educational purposes only. It is not medical advice and should not be used to diagnose, treat, cure, or prevent any disease. Evidence for meshima mushroom is still developing, and most current findings come from laboratory and animal research rather than human clinical trials. Talk with a qualified clinician before starting any new supplement, especially if you are pregnant, breastfeeding, managing a health condition, or taking prescription medicine.